| 标题 |
Abstract RF1-02: Palbociclib plus letrozole versus weekly paclitaxel, both in combination w/ trastuzumab plus pertuzumab, as neoadjuvant treatment for patients w/ HR+/HER2+ early breast cancer: primary results from the randomized phase II TOUCH trial (IBCSG 55-17) |
| 网址 | |
| DOI | |
| 其它 |
期刊:Clinical Cancer Research 作者:Luca Malorni; Svitlana Tyekucheva; C. Zamagni; Ursula Hasler-Strub; Andrea Gombos; et al 出版日期:2025-06-13 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)